Have a personal or library account? Click to login
Correlations Between Covid 19 Symptoms and Risk of Pulmonary Embolism Cover

Correlations Between Covid 19 Symptoms and Risk of Pulmonary Embolism

Open Access
|Oct 2022

References

  1. 1. Sharma A, Ahmad Farouk I, Lal SK. COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention. Viruses. 2021 Jan;13(2).10.3390/v13020202791153233572857
  2. 2. Pyrc K, Berkhout B, van der Hoek L. The novel human coronaviruses NL63 and HKU1. J Virol. 2007 Apr;81(7):3051–7.10.1128/JVI.01466-06186602717079323
  3. 3. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.10.1056/NEJMoa2001017709280331978945
  4. 4. Elena SF, Sanjuán R. Adaptive value of high mutation rates of RNA viruses: separating causes from consequences. J Virol. 2005 Sep;79(18):11555–8.10.1128/JVI.79.18.11555-11558.2005121261416140732
  5. 5. Duffy S. Why are RNA virus mutation rates so damn high? PLoS Biol. 2018;16.10.1371/journal.pbio.3000003610725330102691
  6. 6. Hoque MN, Chaudhury A, Akanda MAM, Hossain MA, Islam MT. 2020. Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease. PeerJ 8:e968910.7717/peerj.9689751047733005486
  7. 7. Del Rio C, Omer SB, Malani PN. Winter of Omicron-The Evolving COVID-19 Pandemic. JAMA. 2022 Jan;327(4):319–20.10.1001/jama.2021.2431534935863
  8. 8. Yu F, Lau L-T, Fok M, Lau JY-N, Zhang K. COVID-19 Delta variants—Current status and implications as of August 2021. Precis Clin Med. 2021 Dec 22;4(4):287–92.10.1093/pcmedi/pbab024849999535692860
  9. 9. To KKW, Hung IFN, Chan JFW, Yuen K-Y. From SARS coronavirus to novel animal and human coronaviruses. J Thorac Dis. 2013 Aug;5 Suppl 2(Suppl 2):S103–8.
  10. 10. Prathipati KK, Mishra M, Rathod B, Tripathy JP, B H S, Bidkar V, et al. Symptomatology and Relationship Between Symptoms and Duration Among COVID-19 Patients in a COVID-19 Care Hospital in Central India. Cureus. 2022 Jan;14(1):e21541.10.7759/cureus.21541886559835223314
  11. 11. Miró Ò, Jiménez S, Mebazaa A, Freund Y, Burillo-Putze G, Martín A, et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome. Eur Heart J. 2021 Sep 1;42(33):3127–42.10.1093/eurheartj/ehab314834471434164664
  12. 12. Roncon L, Zuin M, Barco S, Valerio L, Zuliani G, Zonzin P, et al. Incidence of acute pulmonary embolism in COVID-19 patients: Systematic review and meta-analysis. Eur J Intern Med. 2020 Dec;82:29–37.10.1016/j.ejim.2020.09.006749825232958372
  13. 13. Pellicori P, Doolub G, Wong CM, Lee KS, Mangion K, Ahmad M, et al. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database Syst Rev. 2021;(3).10.1002/14651858.CD013879807834933704775
  14. 14. Fauvel C, et all. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J 2020;41:3058–3068.10.1093/eurheartj/ehaa500752895232656565
  15. 15. Saeed GA, Gaba W, Shah A, Al Helali AA, Raidullah E, Al Ali AB, et al. Correlation between Chest CT Severity Scores and the Clinical Parameters of Adult Patients with COVID-19 Pneumonia. Radiol Res Pract. 2021;2021:6697677.10.1155/2021/6697677780194233505722
  16. 16. Hafez MAF. The mean severity score and its correlation with common computed tomography chest manifestations in Egyptian patients with COVID-2019 pneumonia. Egypt J Radiol Nucl Med. 2020;51(1):254.10.1186/s43055-020-00368-y
  17. 17. Elberts SJ, Bateman R, Koutsoubis A, London KS, White JL, Fields JM. The impact of COVID-19 on the sensitivity of D-dimer for pulmonary embolism. Acad Emerg Med. 2021;28(10):1142–9.10.1111/acem.14348865309334425044
  18. 18. Ventura-Díaz S, Quintana-Pérez J V, Gil-Boronat A, Herrero-Huertas M, Gorospe-Sarasúa L, Montilla J, et al. A higher D-dimer threshold for predicting pulmonary embolism in patients with COVID-19: a retrospective study. Emerg Radiol. 2020;27(6):679–89.10.1007/s10140-020-01859-1753826633025219
  19. 19. Portier I, Campbell RA, Denorme F. Mechanisms of immunothrombosis in COVID-19. Curr Opin Hematol. 2021;28(6):445–53.10.1097/MOH.0000000000000666849028234232139
  20. 20. Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020;69(12):1181–9.10.1007/s00011-020-01401-6748658632918567
DOI: https://doi.org/10.2478/arsm-2021-0016 | Journal eISSN: 1841-4036 | Journal ISSN: 1223-9666
Language: English
Page range: 89 - 93
Published on: Oct 8, 2022
Published by: Ovidius University of Constanta
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Stanciu Ionut Valentin, Zamfir Viorica, Andrei Denisa, Chirila Sergiu, Hangan Laurentiu Tony, Dantes Elena, published by Ovidius University of Constanta
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.